Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "LA"

10517 News Found

We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene
interviews | June 16, 2026

We plan to invest nearly $100 million in new infrastructure, biologics and AI-driven drug discovery,: Akhil Ravi, CEO, Aurigene

Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships


Alithea Genomics and Revvity expand global access to scalable transcriptomics platforms
R&D | June 16, 2026

Alithea Genomics and Revvity expand global access to scalable transcriptomics platforms

Collaboration integrates MERCURIUS DRUG-seq technologies with Revvity’s screening portfolio, enabling scalable transcriptomic profiling for next-generation drug discovery and AI-driven research


India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh
Policy | June 16, 2026

India’s bioeconomy grew 20-fold in last 12 years: Dr Jitendra Singh

From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape


Mabion reactivates MabionCD20 through rare disease collaboration with Oddifact
Biopharma | June 16, 2026

Mabion reactivates MabionCD20 through rare disease collaboration with Oddifact

MabionCD20 is a monoclonal antibody originally developed by Mabion as a biosimilar candidate to MabThera and Rituxan therapies


Lilly’s Jaypirca cuts risk of disease progression or death by 45% in landmark trial
Clinical Trials | June 16, 2026

Lilly’s Jaypirca cuts risk of disease progression or death by 45% in landmark trial

The study enrolled 639 patients, nearly 80% of whom had previously received a covalent BTK inhibitor


Granules India elevates Ananda Babu Doppalapudi as GM and Head Quality for Vizag API Unit
People | June 16, 2026

Granules India elevates Ananda Babu Doppalapudi as GM and Head Quality for Vizag API Unit

Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility


Neuland to set up $20m process development facility in Hyderabad
News | June 16, 2026

Neuland to set up $20m process development facility in Hyderabad

New facility will open by October 2026 and house 500 process development specialists


Dr Reddy’s launches first-to-market generic Bosutinib in US oncology push
News | June 15, 2026

Dr Reddy’s launches first-to-market generic Bosutinib in US oncology push

Dr Reddy’s has partnered with MSN Laboratories Private Limited on the product, with Dr Reddy’s holding exclusive US marketing rights while MSN leads development and manufacturing


Arihant Innochem launches state-of-the-art research & innovation centre in Navi Mumbai
News | June 15, 2026

Arihant Innochem launches state-of-the-art research & innovation centre in Navi Mumbai

The new facility aims to accelerate formulation science and application-led research across pharma, biopharma, nutraceuticals, personal care, and home care segments